Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$0.73 USD
-0.03 (-3.89%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.75 +0.02 (2.46%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
STTK 0.73 -0.03(-3.89%)
Will STTK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STTK
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Other News for STTK
Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I ...
12 Health Care Stocks Moving In Monday's After-Market Session
Strategic Advancements and Promising Pipeline Developments Propel Shattuck Labs’ Buy Rating
Shattuck Labs Advances SL-325 Program Amid Financial Progress